Atchia, K.; Joncas, F.-H.; Trasiewicz, L.S.; Tan, W.P.; Ding, K.; Inman, B.A.; Toren, P.
Follicle-Stimulating Hormone (FSH) Levels During Androgen Deprivation Therapy Are Not Associated with Survival or Development of Castration-Resistant Prostate Cancer. Soc. Int. Urol. J. 2022, 3, 56-61.
https://doi.org/10.48083/LWHQ7760
AMA Style
Atchia K, Joncas F-H, Trasiewicz LS, Tan WP, Ding K, Inman BA, Toren P.
Follicle-Stimulating Hormone (FSH) Levels During Androgen Deprivation Therapy Are Not Associated with Survival or Development of Castration-Resistant Prostate Cancer. Société Internationale d’Urologie Journal. 2022; 3(2):56-61.
https://doi.org/10.48083/LWHQ7760
Chicago/Turabian Style
Atchia, Kaleem, France-Hélène Joncas, Lily Summers Trasiewicz, Wei Phin Tan, Keyue Ding, Brant A. Inman, and Paul Toren.
2022. "Follicle-Stimulating Hormone (FSH) Levels During Androgen Deprivation Therapy Are Not Associated with Survival or Development of Castration-Resistant Prostate Cancer" Société Internationale d’Urologie Journal 3, no. 2: 56-61.
https://doi.org/10.48083/LWHQ7760
APA Style
Atchia, K., Joncas, F.-H., Trasiewicz, L. S., Tan, W. P., Ding, K., Inman, B. A., & Toren, P.
(2022). Follicle-Stimulating Hormone (FSH) Levels During Androgen Deprivation Therapy Are Not Associated with Survival or Development of Castration-Resistant Prostate Cancer. Société Internationale d’Urologie Journal, 3(2), 56-61.
https://doi.org/10.48083/LWHQ7760
